To assess changes in phenotypes, we analyzed the cell surface markers of leukemic stem/progenitor cells using a flow cytometric analysis of CD34- and CD38- expression in 29 paired bulk primary AML cells and the human CD45+ fraction of their engrafted AML-PDX BM cells (Supplementary Table 2). The gene discussed is CD38; the disease is acute myeloid leukemia.